DNA methylation of multiple genes in vestibular schwannoma: Relationship with clinical and radiological findings

Otology and Neurotology

Volumn 27, Issue 8, 2006, Pages 1180-1185

  Lassaletta, Luis ^a   Bello, M Josefa ^a   Del Río, Laura ^a   Alfonso, Carolina ^a   Roda, Jose Maria ^a   Rey, Juan A ^a   Gavilan, Javier ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

DNA methylation; Tumor suppressor gene; Vestibular schwannoma

Indexed keywords

GENOMIC DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CASP8 GENE; CLINICAL ARTICLE; CLINICAL FEATURE; DAPK GENE; DNA METHYLATION; DNA MODIFICATION; ER GENE; FEMALE; GENE SILENCING; GSTP1 GENE; HEARING LOSS; HMLH1 GENE; HUMAN; MALE; MGMT GENE; NEURILEMOMA; PRIORITY JOURNAL; PROMOTER REGION; PTEN GENE; RAR B GENE; RASSF1A GENE; RB1 GENE; THBS1 GENE; TIMP3 GENE; TP14 GENE; TP16 GENE; TP73 GENE; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; VESTIBULAR SCHWANNOMA; VHL GENE;

ADOLESCENT; ADULT; AGED; AUDITORY THRESHOLD; DNA METHYLATION; FEMALE; GENES, TUMOR SUPPRESSOR; HEARING LOSS; HUMANS; MALE; MIDDLE AGED; NEUROMA, ACOUSTIC; PROMOTER REGIONS (GENETICS);

EID: 33845249492     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/01.mao.0000226291.42165.22     Document Type: Article

References (30)

1. Charabi S, Thomsen J, Tos M, et al. Acoustic neuroma/vestibular schwannoma growth: past, present and future. Acta Otolaryngol 1998;118:327-32.
2. Herwadker A, Vokurka EA, Evans DG, et al. Size and growth rate of sporadic vestibular schwannoma: predictive value of information available at presentation. Otol Neurotol 2005;26:86-92.
3. Mohyuddin A, Neary WJ, Wallace A, et al. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas. J Med Genet 2002;39:315-22.
4. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
5. Horiguchi K, Tomizawa Y, Tosaka M, et al. Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors. Oncogene 2003;22:7862-5.
6. Kino T, Takeshima H, Nakao M, et al. Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma. Genes Cells 2001;6:441-54.
7. Gonzalez-Gomez P, Bello MJ, Alonso ME, et al. CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas. Clin Cancer Res 2003;9:5601-6.
8. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985;93:146-7.
9. Graamans K, Van Dijk JE, Janssen LW. Hearing deterioration in patients with a non-growing vestibular schwannoma. Acta Otolaryngol 2003;123:51-4.
10. Caye-Thomasen P, Werther K, Nalla A, et al. VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol 2005;26:98-101.
11. Herman JG, Graff JR, Myohannen S, et al. Methylation specific PCR: a novel assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
12. Bello MJ, Aminoso C, Lopez-Marin I, et al. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Acta Neuropathol (Berl) 2004;108:413-21.
13. Bello MJ, Alonso ME, Aminoso C, et al. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors. Mutat Res 2004;554:23-32.
14. Hung RW, Chow AW. Dissecting the "end game": clinical relevance, molecular mechanisms and laboratory assessment of apoptosis. Clin Invest Med 2004;27:324-44.
15. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, et al. Loss of CASP8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 2000;60:4315-9.
16. Lindsey JC, Lusher ME, Anderton JA, et al. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling. Carcinogenesis 2004;25:661-8.
17. Harada K, Toyooka S, Shivapurkar N, et al. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 2002;62:5897-901.
18. Toyota M, Ahuja N, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-6.
19. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-66.
20. Astuti D, Agathanggelou A, Honorio S, et al. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene 2001;20:7573-7.
21. Romani M, Tonini GP, Banelli B, et al. Biological and clinical role of p73 in neuroblastoma. Cancer Lett 2003;197:111-7.
22. Benard J, Douc-Rasy S, Ahomadegbe JC. TP53 family members and human cancers. Hum Mutat 2003;21:182-91.
23. Stipkovits EM, van Dijk JE, Graamans K. Profile of hearing in patients with unilateral acoustic neuromas: the importance of the contralateral ear. Am J Otol 1998;19:834-9.
24. Allart S, Martin H, Detraves C, et al. Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of deltaN-p73alpha. J Biol Chem 2002;277:29063-8.
25. Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000;25:315-9.
26. Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001;20:1509-18.
27. Choi N, Son DS, Song I, et al. RASSF1A is not appropriate as an early detection marker or a prognostic marker for non-small cell lung cancer. Int J Cancer 2005;115:575-81.
28. Yamaguchi S, Kato H, Miyazaki T, et al. RASSF1A gene promoter methylation in esophageal cancer specimens. Dis Esophagus 2005;18:253-6.
29. Banelli B, Gelvi I, Di Vinci A, et al. Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors. Oncogene 2005;24:5619-28.
30. Mohyuddin A, Vokurka EA, Evans DG, et al. Is clinical growth index a reliable predictor of tumour growth in vestibular schwannomas? Clin Otolaryngol Allied Sci 2003;28:85-90.